RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ConvaTec Group - Stock

ConvaTec Group Equity 2024

ConvaTec Group Equity

1.69 B USD

Ticker

CTEC.L

ISIN

GB00BD3VFW73

WKN

A2AUD3

In 2024, ConvaTec Group's equity was 1.69 B USD, a 5.16% increase from the 1.61 B USD equity in the previous year.

ConvaTec Group Aktienanalyse

What does ConvaTec Group do?

ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. The company was founded in the UK in 1978 and has since established a strong presence in over 100 markets worldwide. Over time, ConvaTec has become a significant leader in the healthcare industry. The company was originally founded by doctors to develop better therapies for patients with chronic diseases and wounds. It started with the development of skincare products for individuals with impaired skin barrier, such as patients with stoma and incontinence. Today, ConvaTec offers a variety of products and therapies for chronic diseases and wounds. ConvaTec operates its business in multiple product segments, each offering unique products and services. These segments include Advanced Wound Care, Infusion Devices, Stoma Care, and Continence and Critical Care. As a company, ConvaTec places a strong emphasis on innovation and research to continuously improve products and meet new medical needs. Collaborating closely with physicians, nursing staff, and patients is also emphasized. ConvaTec offers a comprehensive product portfolio. Advanced Wound Care includes a wide range of wound care products, including hydrocolloid dressings, foam dressings, and other biological collagen products. Infusion Devices consist of pump systems and catheters for administering fluids, medications, and nutrients over an extended period. Stoma Care produces products that support patients with an artificial opening to continue their daily lives as normally as possible. Continence and Critical Care provide solutions for bladder and bowel management of patients in critical situations, such as intensive care units. ConvaTec has become a leading company in the field of medical products and technologies over the years, thanks to its innovative products and a consistent focus on meeting people's needs. Through the use of new technologies and a strong focus on user feedback, ConvaTec has contributed to improving the lives of patients worldwide. Output: ConvaTec Group is a global leading company specialized in the development and manufacturing of medical products and technologies for chronic diseases and wounds. ConvaTec Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing ConvaTec Group's Equity

ConvaTec Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ConvaTec Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating ConvaTec Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

ConvaTec Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in ConvaTec Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about ConvaTec Group Stock

What is the equity of ConvaTec Group this year?

ConvaTec Group has equity of 1.69 B USD this year.

What was the equity of ConvaTec Group compared to the previous year?

The equity of ConvaTec Group has increased/decreased by 5.16% increased compared to the previous year.

What impact does a high equity have on investors of ConvaTec Group?

A high equity is advantageous for investors of ConvaTec Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of ConvaTec Group?

A low equity can be a risk for investors of ConvaTec Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of ConvaTec Group affect the company?

An increase in equity of ConvaTec Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of ConvaTec Group affect the company?

A reduction in equity of ConvaTec Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of ConvaTec Group?

Some factors that can affect the equity of ConvaTec Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of ConvaTec Group so important for investors?

The equity of ConvaTec Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can ConvaTec Group take to change the equity?

To change equity, ConvaTec Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does ConvaTec Group pay?

Over the past 12 months, ConvaTec Group paid a dividend of 0.05 USD . This corresponds to a dividend yield of about 1.7 %. For the coming 12 months, ConvaTec Group is expected to pay a dividend of 0.05 USD.

What is the dividend yield of ConvaTec Group?

The current dividend yield of ConvaTec Group is 1.7 %.

When does ConvaTec Group pay dividends?

ConvaTec Group pays a quarterly dividend. This is distributed in the months of September, May, September, May.

How secure is the dividend of ConvaTec Group?

ConvaTec Group paid dividends every year for the past 0 years.

What is the dividend of ConvaTec Group?

For the upcoming 12 months, dividends amounting to 0.05 USD are expected. This corresponds to a dividend yield of 1.68 %.

In which sector is ConvaTec Group located?

ConvaTec Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von ConvaTec Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ConvaTec Group from 5/23/2024 amounting to 0.035 USD, you needed to have the stock in your portfolio before the ex-date on 4/25/2024.

When did ConvaTec Group pay the last dividend?

The last dividend was paid out on 5/23/2024.

What was the dividend of ConvaTec Group in the year 2023?

In the year 2023, ConvaTec Group distributed 0.046 USD as dividends.

In which currency does ConvaTec Group pay out the dividend?

The dividends of ConvaTec Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ConvaTec Group

Our stock analysis for ConvaTec Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ConvaTec Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.